European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 Countries)
In 2011, the European markets for bone graft substitute, dental membranes and tissue engineering products approached €248 million.
- Austria,
- Benelux (comprising Belgium, the Netherlands and Luxemburg),
- Czech Republic
- France,
- Germany,
- Greece
- Israel,
- Italy,
- Poland
- Portugal,
- Romania
- Scandinavia (comprising Finland, Denmark, Sweden and Norway),
- Spain,
- Switzerland,
- Turkey
- and the United Kingdom
- Dental Bone Graft Substitute Market
- Dental Autograft Potential Market
- Dental Xenograft Market
- Synthetic Bone Graft Substitute Materials Market
- Dental Membrane Market
EXECUTIVE SUMMARY
1.1 EUROPEAN DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKETS
1.2 TREND ANALYSIS BY COUNTRY
1.3 DENTAL BONE GRAFT SUBSTITUTE MARKET
1.4 ALLOGRAFT MARKET
1.5 XENOGRAFT MARKET
1.6 SYNTHETIC MARKET
1.7 DENTAL MEMBRANE MARKET
1.8 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
EUROPEAN DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKETS OVERVIEW
3.1 INTRODUCTION
3.1.1 Applications of Dental Bone Graft Substitutes
3.1.1.1 Dental Implant Procedures
3.1.1.2 Periodontal Procedures
3.1.2 Types of Dental Bone Graft Substitutes
3.1.2.1 Autografts
3.1.2.2 Mineralized Allografts
3.1.2.3 De-Mineralized Bone Matrix (DBM) Allografts
3.1.2.4 Xenografts
3.1.2.5 Synthetics
3.2 TISSUE ENGINEERING PRODUCTS
3.3 DENTAL MEMBRANES
3.4 MARKET PENETRATION AND END USERS
3.5 CURRENCY EXCHANGE RATES
3.6 MARKET OVERVIEW
3.7 MARKET BY SEGMENT
3.7.1 Dental Bone Grafting Substitute Market
3.7.2 Material Volume Sold by BGS Type
3.7.3 Autograft Market
3.7.4 Mineralized Allograft Market
3.7.5 De-Mineralized Bone Matrix (DBM) Market
3.7.6 Xenograft Market
3.7.7 Synthetic Biomaterials Market
3.7.8 Dental Membrane Market
3.8 PROCEDURE NUMBERS
3.9 MARKET BY COUNTRY
3.10 MARKET DRIVERS AND LIMITERS
3.10.1 Market Drivers
3.10.2 Market Limiters
3.11 COMPETITIVE ANALYSIS
3.11.1 Other Notable Competitors
3.11.2 Growth Factor Potential Competitors
3.12 MERGERS AND ACQUISITIONS
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP per Capita
4.1.3 Price Index
4.2 EUROPEAN BONE GRAFT SUBSTITUTE PER CAPITA SUMMARY
4.2.1 Bone Graft Substitute Volume Used per 10,000 Inhabitants
4.3 GERMANY
4.4 FRANCE
4.5 U.K.
4.6 ITALY
4.7 SPAIN
4.8 BENELUX
4.9 SCANDINAVIA
4.10 AUSTRIA
4.11 SWITZERLAND
4.12 PORTUGAL
4.13 EUROPEAN TOOTH LOSS STATISTICS
4.14 DENTISTS PER POPULATION AND DENTAL IMPLANT PROCEDURE COSTS BY COUNTRY
DENTAL BONE GRAFT SUBSTITUTE MARKET
5.1 INTRODUCTION
5.2 DENTAL BONE GRAFTING PROCEDURE NUMBERS
5.2.1 Volume of Bone Graft Substitute Used per Implant Procedure
5.3 MARKET OVERVIEW
5.4 MARKET ANALYSIS AND FORECAST
5.5 MATERIAL VOLUME SOLD BY BGS TYPE
5.5.1 Autograft Market
5.5.2 Mineralized Allograft Market
5.5.3 De-Mineralized Bone Matrix (DBM) Market
5.5.4 Xenograft Market
5.5.5 Synthetic Market
5.6 MARKET DRIVERS AND LIMITERS
5.6.1 Market Drivers
5.6.2 Market Limiters
5.7 COMPETITIVE ANALYSIS
DENTAL MEMBRANE MARKET
6.1 INTRODUCTION
6.2 MARKET ANALYSIS AND FORECAST
6.3 MARKET DRIVERS AND LIMITERS
6.3.1 Market Limiters
6.4 COMPETITIVE ANALYSIS
EMDOGAIN® MARKET
7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
POTENTIAL MARKETS FOR DENTAL GROWTH FACTORS
8.1 INTRODUCTION
8.1.1 GEM 21S®
8.1.2 INFUSE®
8.1.3 Platelet Rich Plasma (PRP)
8.1.4 Osteocel®
8.2 MARKET ANALYSIS AND FORECAST
8.2.1 GEM 21S® Market
8.3 COMPETITIVE ANALYSIS
APPENDIX: ISRAEL, POLAND, ROMANIA, TURKEY, GREECE AND CZECH REPUBLIC DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET
9.1 INTRODUCTION
9.2 ISRAEL, POLAND, ROMANIA, TURKEY, GREECE AND CZECH REPUBLIC DENTAL BONE GRAFT SUBSTITUTE MARKET
9.3 MATERIAL VOLUME SOLD BY BGS TYPE
9.3.1 Autograft Market
9.3.2 Mineralized Allograft Market, Israel, Poland, Romania, Turkey, Greece and Czech Republic
9.3.3 De-Mineralized Bone Matrix (DBM) Market
9.3.4 Xenograft Market
9.3.5 Synthetic Market
9.4 COMPETITIVE ANALYSIS
ABBREVIATIONS
1.1 EUROPEAN DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKETS
1.2 TREND ANALYSIS BY COUNTRY
1.3 DENTAL BONE GRAFT SUBSTITUTE MARKET
1.4 ALLOGRAFT MARKET
1.5 XENOGRAFT MARKET
1.6 SYNTHETIC MARKET
1.7 DENTAL MEMBRANE MARKET
1.8 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
EUROPEAN DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKETS OVERVIEW
3.1 INTRODUCTION
3.1.1 Applications of Dental Bone Graft Substitutes
3.1.1.1 Dental Implant Procedures
3.1.1.2 Periodontal Procedures
3.1.2 Types of Dental Bone Graft Substitutes
3.1.2.1 Autografts
3.1.2.2 Mineralized Allografts
3.1.2.3 De-Mineralized Bone Matrix (DBM) Allografts
3.1.2.4 Xenografts
3.1.2.5 Synthetics
3.2 TISSUE ENGINEERING PRODUCTS
3.3 DENTAL MEMBRANES
3.4 MARKET PENETRATION AND END USERS
3.5 CURRENCY EXCHANGE RATES
3.6 MARKET OVERVIEW
3.7 MARKET BY SEGMENT
3.7.1 Dental Bone Grafting Substitute Market
3.7.2 Material Volume Sold by BGS Type
3.7.3 Autograft Market
3.7.4 Mineralized Allograft Market
3.7.5 De-Mineralized Bone Matrix (DBM) Market
3.7.6 Xenograft Market
3.7.7 Synthetic Biomaterials Market
3.7.8 Dental Membrane Market
3.8 PROCEDURE NUMBERS
3.9 MARKET BY COUNTRY
3.10 MARKET DRIVERS AND LIMITERS
3.10.1 Market Drivers
3.10.2 Market Limiters
3.11 COMPETITIVE ANALYSIS
3.11.1 Other Notable Competitors
3.11.2 Growth Factor Potential Competitors
3.12 MERGERS AND ACQUISITIONS
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP per Capita
4.1.3 Price Index
4.2 EUROPEAN BONE GRAFT SUBSTITUTE PER CAPITA SUMMARY
4.2.1 Bone Graft Substitute Volume Used per 10,000 Inhabitants
4.3 GERMANY
4.4 FRANCE
4.5 U.K.
4.6 ITALY
4.7 SPAIN
4.8 BENELUX
4.9 SCANDINAVIA
4.10 AUSTRIA
4.11 SWITZERLAND
4.12 PORTUGAL
4.13 EUROPEAN TOOTH LOSS STATISTICS
4.14 DENTISTS PER POPULATION AND DENTAL IMPLANT PROCEDURE COSTS BY COUNTRY
DENTAL BONE GRAFT SUBSTITUTE MARKET
5.1 INTRODUCTION
5.2 DENTAL BONE GRAFTING PROCEDURE NUMBERS
5.2.1 Volume of Bone Graft Substitute Used per Implant Procedure
5.3 MARKET OVERVIEW
5.4 MARKET ANALYSIS AND FORECAST
5.5 MATERIAL VOLUME SOLD BY BGS TYPE
5.5.1 Autograft Market
5.5.2 Mineralized Allograft Market
5.5.3 De-Mineralized Bone Matrix (DBM) Market
5.5.4 Xenograft Market
5.5.5 Synthetic Market
5.6 MARKET DRIVERS AND LIMITERS
5.6.1 Market Drivers
5.6.2 Market Limiters
5.7 COMPETITIVE ANALYSIS
DENTAL MEMBRANE MARKET
6.1 INTRODUCTION
6.2 MARKET ANALYSIS AND FORECAST
6.3 MARKET DRIVERS AND LIMITERS
6.3.1 Market Limiters
6.4 COMPETITIVE ANALYSIS
EMDOGAIN® MARKET
7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
POTENTIAL MARKETS FOR DENTAL GROWTH FACTORS
8.1 INTRODUCTION
8.1.1 GEM 21S®
8.1.2 INFUSE®
8.1.3 Platelet Rich Plasma (PRP)
8.1.4 Osteocel®
8.2 MARKET ANALYSIS AND FORECAST
8.2.1 GEM 21S® Market
8.3 COMPETITIVE ANALYSIS
APPENDIX: ISRAEL, POLAND, ROMANIA, TURKEY, GREECE AND CZECH REPUBLIC DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET
9.1 INTRODUCTION
9.2 ISRAEL, POLAND, ROMANIA, TURKEY, GREECE AND CZECH REPUBLIC DENTAL BONE GRAFT SUBSTITUTE MARKET
9.3 MATERIAL VOLUME SOLD BY BGS TYPE
9.3.1 Autograft Market
9.3.2 Mineralized Allograft Market, Israel, Poland, Romania, Turkey, Greece and Czech Republic
9.3.3 De-Mineralized Bone Matrix (DBM) Market
9.3.4 Xenograft Market
9.3.5 Synthetic Market
9.4 COMPETITIVE ANALYSIS
ABBREVIATIONS